ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 187 filers reported holding ANI PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,466,273 | +127.2% | 42,478 | +110.7% | 0.00% | +100.0% |
Q2 2023 | $1,085,374 | +129.8% | 20,163 | +69.5% | 0.00% | +100.0% |
Q1 2023 | $472,390 | -4.6% | 11,893 | -3.3% | 0.00% | 0.0% |
Q4 2022 | $494,950 | +23.7% | 12,303 | -1.2% | 0.00% | 0.0% |
Q3 2022 | $400,000 | +0.5% | 12,453 | -7.3% | 0.00% | 0.0% |
Q2 2022 | $398,000 | -19.3% | 13,428 | -23.4% | 0.00% | 0.0% |
Q1 2022 | $493,000 | -33.1% | 17,538 | +9.7% | 0.00% | 0.0% |
Q4 2021 | $737,000 | -15.1% | 15,988 | -39.6% | 0.00% | 0.0% |
Q3 2021 | $868,000 | -40.9% | 26,459 | -36.8% | 0.00% | -50.0% |
Q2 2021 | $1,468,000 | -40.2% | 41,886 | -38.3% | 0.00% | -50.0% |
Q1 2021 | $2,455,000 | +100.1% | 67,918 | +60.8% | 0.00% | +100.0% |
Q4 2020 | $1,227,000 | +256.7% | 42,233 | +246.7% | 0.00% | +100.0% |
Q3 2020 | $344,000 | -11.6% | 12,183 | +1.2% | 0.00% | 0.0% |
Q2 2020 | $389,000 | -35.7% | 12,040 | -19.0% | 0.00% | 0.0% |
Q1 2020 | $605,000 | -35.0% | 14,857 | -1.6% | 0.00% | 0.0% |
Q4 2019 | $931,000 | -15.7% | 15,098 | -0.3% | 0.00% | -50.0% |
Q3 2019 | $1,104,000 | -28.6% | 15,148 | -19.5% | 0.00% | 0.0% |
Q2 2019 | $1,547,000 | +17.1% | 18,818 | +0.4% | 0.00% | 0.0% |
Q1 2019 | $1,321,000 | +66.2% | 18,737 | +6.2% | 0.00% | +100.0% |
Q4 2018 | $795,000 | -24.0% | 17,649 | -4.6% | 0.00% | -50.0% |
Q3 2018 | $1,046,000 | -21.8% | 18,492 | -7.6% | 0.00% | 0.0% |
Q2 2018 | $1,338,000 | +41.6% | 20,022 | +23.4% | 0.00% | +100.0% |
Q1 2018 | $945,000 | -2.6% | 16,222 | +7.8% | 0.00% | 0.0% |
Q4 2017 | $970,000 | +21.4% | 15,050 | -1.2% | 0.00% | 0.0% |
Q3 2017 | $799,000 | +22.4% | 15,230 | +9.2% | 0.00% | 0.0% |
Q2 2017 | $653,000 | -6.3% | 13,950 | -0.9% | 0.00% | 0.0% |
Q1 2017 | $697,000 | -17.1% | 14,080 | +1.4% | 0.00% | 0.0% |
Q4 2016 | $841,000 | -13.0% | 13,880 | -4.7% | 0.00% | -50.0% |
Q3 2016 | $967,000 | -7.4% | 14,570 | -22.1% | 0.00% | 0.0% |
Q2 2016 | $1,044,000 | +68.4% | 18,700 | +1.6% | 0.00% | +100.0% |
Q1 2016 | $620,000 | -23.7% | 18,410 | +2.2% | 0.00% | 0.0% |
Q4 2015 | $813,000 | +11.8% | 18,010 | -2.2% | 0.00% | 0.0% |
Q3 2015 | $727,000 | -38.4% | 18,410 | -3.3% | 0.00% | -50.0% |
Q2 2015 | $1,181,000 | +1.9% | 19,030 | +2.7% | 0.00% | 0.0% |
Q1 2015 | $1,159,000 | – | 18,530 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Mesirow Financial Investment Management, Inc. | 9,433 | $266,000 | 1.14% |
Global Alpha Capital Management Ltd. | 258,946 | $7,305,000 | 1.12% |
Birch Grove Capital LP | 50,791 | $1,433,000 | 0.78% |
1492 Capital Management LLC | 25,003 | $705,000 | 0.53% |
INVESTMENT COUNSELORS OF MARYLAND LLC | 321,975 | $9,083,000 | 0.41% |
THB ASSET MANAGEMENT | 48,385 | $1,364,000 | 0.38% |
Regent Investment Management LLC | 36,979 | $1,043,000 | 0.32% |
GLOBEFLEX CAPITAL L P | 41,212 | $1,163,000 | 0.31% |
HUSSMAN STRATEGIC ADVISORS, INC. | 35,500 | $1,001,000 | 0.26% |
Ranger Investment Management | 124,763 | $3,520,000 | 0.22% |